Talk to an expert liver nurse: 1800 841 118

Supporting GPs In The Fight Against Liver Disease

The Liver Foundation has launched brand new GP Education and it’s getting rave reviews from GPs.

Liver diseases cost Australia 40% more than type 2 diabetes and chronic kidney diseases combined. Metabolic-associated fatty liver disease (MAFLD) is the most prevalent liver disease in history. But knowledge of this condition among GPs is generally poor, given the scale of the challenge and the potential seriousness of the disease.

If left untreated, liver disease can progress to irreversible cirrhosis of the liver – which is the greatest risk factor for hepatocellular carcinoma, the most rapidly rising cause of cancer death in Australia.

The Liver Foundation has launched ‘The rising health threat of liver disease: What GPs can do to prevent premature mortality’ 5 hour advanced course for GPs to update their knowledge on the best-practice diagnosis and management of liver disease.

In this 5-hour course, participants will learn how to identify, manage and support patients with liver disease. GPs can register for this important course on the ThinkGP website: https://www.thinkgp.com.au/education/rising-health-threat-liver-disease

We’ve also launched a clinical audit in which GPs can conduct an assessment of patients who are at risk of MAFLD, calculate their risk of liver fibrosis using validated tools and decide on further management. It’s designed to support GPs to manage patients who are 35 years or older, have risk factors for MAFLD including overweigh tor obesity, type 2 diabetes, metabolic syndrome, abnormal liver blood tests or hepatic steatosis, and who have not already been referred to a hepatologist. GPs can register for the Clinical Audit for free here: https://www.thinkgp.com.au/education/mafld-clinical-audit.

Both the Advanced Course and the Clinical Audit are free to GPs and are fully accredited for CPD with RACGP and ACRRM.

This education was funded by the Australian Government Department of Health and Aged Care and Roche Diagnostics.

Subscribe To Our Newsletter

Keep up to date with activities, campaigns, developments and news.

This field is for validation purposes and should be left unchanged.